Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Cholecystokinin Receptor
    (6)
  • Drug-Linker Conjugates for ADC
    (1)
  • Others
    (7)
Filter
Search Result
Results for "

cck2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    15
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    1
    TargetMol | Natural_Products
itriglumide
CR-2945, CR2945, CR 2945
T27640201605-51-8In house
Itriglumide (CR-2945) is a cholecystokinin (CCK)-2 receptor antagonist with antisecretory and antiulcerogenic properties.
  • Inquiry Price
6-8 weeks
Size
QTY
CCK2R Ligand-Linker Conjugates 1
T177271452145-13-9
CCK2R Ligand-Linker Conjugate 1 is a hydrophilic peptide linker that conjugates to the cytotoxic antimicrotubule agents Desacetyl Vinblastine Hydrazide (DAVBH) and Tubulysin B Hydrazide (TubBH) as ligand-linker conjugates[1].
  • Inquiry Price
Size
QTY
GV150013
GV 150013, GV-150013
T27503167355-22-8In house
GV150013 is an antagonist of cholecystokinin-2 (CCK2) receptor.
  • Inquiry Price
8-10 weeks
Size
QTY
TargetMol | Inhibitor Sale
Lintitript
SR 27897
T15759136381-85-6In house
Lintitript (SR 27897) is a selective CCK1 antagonist with an EC50 of 6 nM for CCK1 and 200 nM for CCK2, and a Ki value of 0.2 nM for CCK1.
  • Inquiry Price
Size
QTY
Gastrin I (human) acetate
Gastrin I (human) acetate(10047-33-3 free base), Gastrin-17 acetate, Little gastrin I acetate
TP2030L1
Gastrin I (human) acetate (Gastrin-17 acetate) is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Gastrazole free acid
JB-95008, Gastrazole, JB 95008, JB95008
T24085174610-98-1
Gastrazole is a CCK2 receptor antagonist potentially. It also used for the treatment of pancreatic cancer.
  • Inquiry Price
6-8 weeks
Size
QTY
Nastorazepide
Z-360
TQ0062209219-38-5
Nastorazepide (Z-360) is a selective, orally available antagonist of the gastrin cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
  • Inquiry Price
Size
QTY
LY 225910
T22941133040-77-4
LY 225910 is a CCK2 receptor antagonist.
  • Inquiry Price
6-8 weeks
Size
QTY
PNB-001
T872271528760-09-9
PNB-001 is an orally active, CCK2-selective ligand and antagonist with anti-inflammatory and analgesic activities [1].
  • Inquiry Price
10-14 weeks
Size
QTY
JNJ-26070109
JNJ26070109
T27669844645-08-5
JNJ-26070109, an antagonist of cholecystokinin CCK2 receptor, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.
  • Inquiry Price
6-8 weeks
Size
QTY
pd 135158
T23125130325-35-8
PD 135158 is a CCK2 receptor antagonist.
  • Inquiry Price
10-14 weeks
Size
QTY
CI-988
CI 988
T22666130332-27-3
CCK2 (CCK-B) receptor antagonist
  • Inquiry Price
10-14 weeks
Size
QTY
LY288513
LY 288513
T22949147523-65-7
Selective CCK2 receptor antagonist
  • Inquiry Price
6-8 weeks
Size
QTY
Gastrin I, human
Gastrin I (human)
TP203010047-33-3
Gastrin I, human (Gastrin I (human)) is an endogenous peptide produced in the stomach that increases pepsinogen and acid secretion via the CCK2 receptor in the rat.
  • Inquiry Price
7-10 days
Size
QTY
Gastrazole disodium
JB-95008, JB95008, JB 95008, Gastrazole sodium
T27403862583-15-1
Gastrazole, a CCK2 receptor antagonist, is used potentially for the treatment of pancreatic cancer.
  • Inquiry Price
6-8 weeks
Size
QTY